A carregar...

Specific Activities of Dolastatin 10 and Peptide Derivatives against Cryptococcus neoformans

The biosynthetic peptide dolastatin 10 is currently in phase I and II cancer clinical trials. We evaluated the antifungal spectrum of dolastatin 10 and four structural modifications. In broth macrodilution assays, the peptides were fungicidal for American Type Culture Collection strains and clinical...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pettit, Robin K., Pettit, George R., Hazen, Kevin C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 1998
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC105973/
https://ncbi.nlm.nih.gov/pubmed/9797233
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!